Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

264 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metastatic Sites' Location and Impact on Patient Management After the Introduction of Prostate-specific Membrane Antigen Positron Emission Tomography in Newly Diagnosed and Biochemically Recurrent Prostate Cancer: A Critical Review.
Mattana F, Muraglia L, Rajwa P, Zattoni F, Marra G, Chiu PKF, Heidegger I, Kasivisvanathan V, Kesch CV, Olivier J, Preisser F, Thibault C, Valerio M, van den Bergh RCN, Gandaglia G, Ceci F; European Association of Urology Young Academic Urologists Prostate Cancer Working Party. Mattana F, et al. Among authors: ceci f. Eur Urol Oncol. 2023 Apr;6(2):128-136. doi: 10.1016/j.euo.2023.01.014. Epub 2023 Feb 16. Eur Urol Oncol. 2023. PMID: 36804735 Free article. Review.
Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review.
Marra G, Valerio M, Heidegger I, Tsaur I, Mathieu R, Ceci F, Ploussard G, van den Bergh RCN, Kretschmer A, Thibault C, Ost P, Tilki D, Kasivisvanathan V, Moschini M, Sanchez-Salas R, Gontero P, Karnes RJ, Montorsi F, Gandaglia G; EAU-YAU Prostate Cancer Working Party. Marra G, et al. Among authors: ceci f. Eur Urol Oncol. 2020 Oct;3(5):565-581. doi: 10.1016/j.euo.2020.08.005. Epub 2020 Sep 12. Eur Urol Oncol. 2020. PMID: 32933887
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy?
Heidegger I, Necchi A, Pircher A, Tsaur I, Marra G, Kasivisvanathan V, Kretschmer A, Mathieu R, Ceci F, van den Bergh RCN, Thibault C, Tilki D, Valerio M, Surcel C, Gandaglia G; EAU-YAU Prostate Cancer Working Party. Heidegger I, et al. Among authors: ceci f. Eur Urol Oncol. 2021 Oct;4(5):745-754. doi: 10.1016/j.euo.2020.10.010. Epub 2020 Nov 23. Eur Urol Oncol. 2021. PMID: 33243663 Review.
Radiation Therapy After Radical Prostatectomy: What Has Changed Over Time?
Zattoni F, Heidegger I, Kasivisvanathan V, Kretschmer A, Marra G, Magli A, Preisser F, Tilki D, Tsaur I, Valerio M, van den Bergh R, Kesch C, Ceci F, Fankhauser C, Gandaglia G. Zattoni F, et al. Among authors: ceci f. Front Surg. 2021 Jul 9;8:691473. doi: 10.3389/fsurg.2021.691473. eCollection 2021. Front Surg. 2021. PMID: 34307443 Free PMC article. Review.
Focal Therapy for Prostate Cancer: Complications and Their Treatment.
Rakauskas A, Marra G, Heidegger I, Kasivisvanathan V, Kretschmer A, Zattoni F, Preisser F, Tilki D, Tsaur I, van den Bergh R, Kesch C, Ceci F, Fankhauser C, Gandaglia G, Valerio M. Rakauskas A, et al. Among authors: ceci f. Front Surg. 2021 Jul 12;8:696242. doi: 10.3389/fsurg.2021.696242. eCollection 2021. Front Surg. 2021. PMID: 34322516 Free PMC article. Review.
Features and management of men with pN1 cM0 prostate cancer after radical prostatectomy and lymphadenectomy: a systematic review of population-based evidence.
Laine C, Gandaglia G, Valerio M, Heidegger I, Tsaur I, Olivier J, Ceci F, van den Bergh RCN, Kretschmer A, Thibault C, Chiu PK, Tilki D, Kasivisvanathan V, Preisser F, Zattoni F, Fankhauser C, Kesch C, Puche-Sanz I, Moschini M, Pradere B, Ploussard G, Marra G; EAU-YAU Prostate Cancer Working Party. Laine C, et al. Among authors: ceci f. Curr Opin Urol. 2022 Jan 1;32(1):69-84. doi: 10.1097/MOU.0000000000000946. Curr Opin Urol. 2022. PMID: 34812201 Free article.
Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence.
Bianchi L, Castellucci P, Farolfi A, Droghetti M, Artigas C, Leite J, Corona P, Shagera QA, Moreira R, González C, Queiroz M, de Galiza Barbosa F, Schiavina R, Deandreis D, Fanti S, Ceci F. Bianchi L, et al. Among authors: ceci f. Eur Urol Oncol. 2023 Feb;6(1):41-48. doi: 10.1016/j.euo.2021.12.002. Epub 2021 Dec 20. Eur Urol Oncol. 2023. PMID: 34933814
Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives.
Kretschmer A, van den Bergh RCN, Martini A, Marra G, Valerio M, Tsaur I, Heidegger I, Kasivisvanathan V, Kesch C, Preisser F, Fankhauser CD, Zattoni F, Ceci F, Olivier J, Chiu P, Puche-Sanz I, Thibault C, Gandaglia G, Tilki D, On Behalf Of The Yau Prostate Cancer Working Group. Kretschmer A, et al. Among authors: ceci f. Cancers (Basel). 2021 Dec 29;14(1):147. doi: 10.3390/cancers14010147. Cancers (Basel). 2021. PMID: 35008310 Free PMC article. Review.
Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review.
Heidegger I, Kesch C, Kretschmer A, Tsaur I, Ceci F, Valerio M, Tilki D, Marra G, Preisser F, Fankhauser CD, Zattoni F, Chiu P, Puche-Sanz I, Olivier J, van den Bergh RCN, Kasivisvanathan V, Pircher A, Virgolini I, Gandaglia G. Heidegger I, et al. Among authors: ceci f. Ther Adv Med Oncol. 2022 Mar 5;14:17588359221081922. doi: 10.1177/17588359221081922. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35273651 Free PMC article. Review.
264 results